It’s been a whirlwind of a week, and it’s only Tuesday. Today on Post-Hoc Live at 11 a.m. ET, I’ll be sitting down with my colleague from the Financial Times, Global Pharmaceutical Editor Hannah Kuchler. As we gear up for the FT and Endpoints News Global Pharma and Biotech Summit in London next week, we wanted to give you a sneak peek into the topics we’ll be diving into and how we are tackling the chaotic stories that are dominating our coverage right now.
Join us on YouTube or set a calendar reminder for our live session in just a few hours as we delve into the latest M&A drama involving Pfizer, Metsera, and Novo Nordisk, hot on the heels of Pfizer’s earnings call. We will also be discussing the new Novo and its dynamic CEO, as well as the current happenings in Washington, D.C., from the FDA shakeup to our predictions for the upcoming MFN announcements. Hannah will also be sharing her insights from the UK on how our European counterparts are viewing the unfolding events in the US.
For those of you interested in attending the Global Pharma and Biotech Summit in London either in person or virtually, be sure to check out the agenda. Use the code POSTHOC20 to save on your virtual registration.
We look forward to seeing you in a few hours as we unpack the latest developments in the pharmaceutical and biotech industries. Stay tuned for an engaging and informative discussion with Hannah and myself.
